BioNet Pharma GmbH, Protein Design Labs deal

PDLI licensed its humanized Anti-L-Selectin Antibody to BioNet in Europe, the Middle East and Africa. PDLI received a $3 million signing and licensing fee and is eligible for royalties. BioNet will re...